Understanding how the SARS-CoV-2 virus packages its genetic material
A multipronged investigation of SARS-CoV-2 genome packaging
This study is looking at how the SARS-CoV-2 virus organizes its genetic material, focusing on a specific protein that helps it do this, with the hope of finding new ways to create treatments that could stop the virus from spreading in patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11056752 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind how the SARS-CoV-2 virus packages its genome, which is crucial for its lifecycle. The focus is on the Nucleocapsid (N) protein, which plays a key role in binding and compacting the viral RNA. By studying the interactions of this protein, particularly its disordered regions, the research aims to identify potential therapeutic targets that could disrupt the virus's ability to replicate. Patients may benefit from insights gained that could lead to new antiviral treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals affected by COVID-19 or those at high risk of severe illness from the virus.
Not a fit: Patients who are not affected by COVID-19 or who have already recovered from the virus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that effectively target SARS-CoV-2.
How similar studies have performed: Other research has shown promise in targeting viral proteins for therapeutic intervention, suggesting that this approach could yield significant results.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Soranno, Andrea — Washington University
- Study coordinator: Soranno, Andrea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.